IR HOME NEWS & EVENTS OVERVIEW PRESS RELEASES EVENTS & PRESENTATIONS STOCK INFORMATION OVERVIEW HISTORIC STOCK LOOKUP INVESTMENT CALCULATOR ANALYST COVERAGE FINANCIALS & FILINGS OVERVIEW SEC FILINGS CORPORATE GOVERNANCE OVERVIEW LEADERSHIP BOARD OF DIRECTORS COMMITTEE COMPOSITION CONTACT IR IR HOME NEWS & EVENTS OVERVIEW PRESS RELEASES EVENTS & PRESENTATIONS STOCK INFORMATION OVERVIEW HISTORIC STOCK LOOKUP INVESTMENT CALCULATOR ANALYST COVERAGE FINANCIALS & FILINGS OVERVIEW SEC FILINGS CORPORATE GOVERNANCE OVERVIEW LEADERSHIP BOARD OF DIRECTORS COMMITTEE COMPOSITION CONTACT IR "Non-systemic drugs: a critical review" published in Current Pharmaceutical Design Read more about "Non-systemic drugs: a critical review" published in Current Pharmaceutical Design Ardelyx, Inc. Closes $30M Series B Financing Read more about Ardelyx, Inc. Closes $30M Series B Financing Ardelyx Appoints Mark Kaufmann to Chief Business Officer Read more about Ardelyx Appoints Mark Kaufmann to Chief Business Officer Matthew L. Kaplan Matthew L. Kaplan Ladenburg Thalmann Yigal Nochomovitz, Ph.D. Yigal Nochomovitz, Ph.D. Citi Research Robert Bazemore Member of the Compensation Committee Robert Bazemore William Bertrand William Bertrand Jr. William Bertrand Member of the Audit and Compliance CommitteeChair of the Nominating and Governance Committee William Bertrand Jr. David Mott Chair of the Compensation CommitteeMember of the Audit and Compliance Committee David Mott Annalisa Jenkins Annalisa Jenkins Pagination First page « First Previous page ‹ Previous … Page 21 Page 22 Page 23 Page 24 Page 25 Page 26 Page 27 Current page 28 Page 29 Next page Next › Last page Last » Subscribe to FAQs Email Alerts Connect
"Non-systemic drugs: a critical review" published in Current Pharmaceutical Design Read more about "Non-systemic drugs: a critical review" published in Current Pharmaceutical Design
Ardelyx, Inc. Closes $30M Series B Financing Read more about Ardelyx, Inc. Closes $30M Series B Financing
Ardelyx Appoints Mark Kaufmann to Chief Business Officer Read more about Ardelyx Appoints Mark Kaufmann to Chief Business Officer
William Bertrand Member of the Audit and Compliance CommitteeChair of the Nominating and Governance Committee William Bertrand Jr.
David Mott Chair of the Compensation CommitteeMember of the Audit and Compliance Committee David Mott